Edward Allera and Barbara Binzak Blumenfield, Shareholders in the firm's FDA & Biotechnology section, and Associates Alexandre Gapihan and Tina Hu-Rogers' representation of two drugmaker clients in their fight to prevent FDA from rescinding those companies' generic laxative prescription drug approvals is detailed in Law360's "Drugmakers Assail FDA for Nixing Generic Laxative Approval."